Clinical Trials
3 trialsNCT00882973 2017-05-05
Trial to Determine the Maximum Tolerated Dose of Genexol-PM Plus Gemcitabine and Evaluate Efficacy and Safety of Genexol-PM Regimens in Subjects With Advanced Pancreatic Cancer
Samyang Biopharmaceuticals Corporation
Phase 1 Completed
NCT02739529 2017-05-01
Study to Evaluate the Efficacy and Safety of Genexol-PM Once a Week for Gynecologic Cancer
Samyang Biopharmaceuticals Corporation
Phase 1 Unknown
NCT00877253 2012-06-12
Determine MTD, Evaluate Efficacy and Safety of Genexol®-PM Plus Carboplatin With Advanced Ovarian Cancer
Samyang Biopharmaceuticals Corporation
Phase 1 Completed